首页> 外国专利> Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl

Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl

机译:支架蛋白的细胞可渗透抑制剂大量的SH3结构域(POSH)或Sh3Rfl

摘要

Here, we identify Plenty of SH3 (POSH) and JNK-interacting protein 1 (JIP-1) as a multi-protein scaffold network for TCR-mediated JNK1 activation in CD8+ T-cells. Disruption of the POSH/JIP-1 complex led to profound defects in the activation of JNK1, as well as deficient activation or induction of the transcription factors c-Jun, T-bet and Eomesodermin. Furthermore, disruption of the POSH/JIP complex in CD8+ T-cells resulted in impaired proliferation, decreased cytokine expression and the inability to control tumors. Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8+ T-cell responses. A group of compounds are described that individually or in concert target a common set of biological pathways important in T cell function, activation of innate inflammation, ischemic reperfusion injury, HIV release and oncogenesis.
机译:在这里,我们确定大量的SH3(POSH)和JNK相互作用蛋白1(JIP-1)作为TCR介导的JNK1激活CD8 + T细胞中的多蛋白支架网络。 POSH / JIP-1复合物的破坏导致JNK1激活中的严重缺陷,以及转录因子c-Jun,T-bet和Eomesodermin的激活或诱导不足。此外,CD8 + T细胞中POSH / JIP复合物的破坏导致增殖受损,细胞因子表达降低和无法控制肿瘤。总体而言,这些数据确定了特定调节TCR依赖的JNK1激活和功能的机制,这是CD8 + T细胞反应的关键。描述了一组化合物,这些化合物单独或共同靶向于一组对T细胞功能,先天性炎症的活化,缺血性再灌注损伤,HIV释放和致癌作用重要的生物学途径。

著录项

  • 公开/公告号US9901617B2

    专利类型

  • 公开/公告日2018-02-27

    原文格式PDF

  • 申请/专利权人 THE CURATORS OF THE UNIVERSITY OF MISSOURI;

    申请/专利号US201414911939

  • 发明设计人 MARK A. DANIELS;

    申请日2014-08-14

  • 分类号A61K38/00;C07K14/47;C07K7/08;C12N7/00;A61K38/17;A61K47/48;C07K14/005;

  • 国家 US

  • 入库时间 2022-08-21 12:55:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号